Phase II Trial of Dolastatin-10, a Novel Anti-Tubulin Agent, in Metastatic Soft Tissue Sarcomas
about
Stabilizing versus destabilizing the microtubules: a double-edge sword for an effective cancer treatment option?Nature's bounty - drug discovery from the seaManagement of relapsed or refractory hodgkin lymphoma with second-generation antibody-drug conjugates: focus on brentuximab vedotin.Microtubule destabilising agents: far more than just antimitotic anticancer drugs.
P2860
Phase II Trial of Dolastatin-10, a Novel Anti-Tubulin Agent, in Metastatic Soft Tissue Sarcomas
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Phase II Trial of Dolastatin-1 ...... etastatic Soft Tissue Sarcomas
@ast
Phase II Trial of Dolastatin-1 ...... etastatic Soft Tissue Sarcomas
@en
type
label
Phase II Trial of Dolastatin-1 ...... etastatic Soft Tissue Sarcomas
@ast
Phase II Trial of Dolastatin-1 ...... etastatic Soft Tissue Sarcomas
@en
prefLabel
Phase II Trial of Dolastatin-1 ...... etastatic Soft Tissue Sarcomas
@ast
Phase II Trial of Dolastatin-1 ...... etastatic Soft Tissue Sarcomas
@en
P2093
P2860
P1433
P1476
Phase II Trial of Dolastatin-1 ...... etastatic Soft Tissue Sarcomas
@en
P2093
J H Edmonson
M von Mehren
S McLaughlin
S P Balcerzak
P2860
P304
P356
10.1080/13577140400009163
P577
2004-01-01T00:00:00Z